Bicara Therapeutics
Healthcare
Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Their lead program, ficerafusp alfa, is a bifunctional antibody targeting EGFR and TGF-β to exert potent anti-tumor activity.
Visit website